Literature DB >> 8280494

Amplified met gene linked to double minutes in human glioblastoma.

B Wullich, H W Müller, U Fischer, K D Zang, E Meese.   

Abstract

The met proto-oncogene was found to be amplified in a human glioblastoma cell line (T3095) established from a glioblastoma multiform WHO grade IV. Amplification of epidermal growth factor receptor, transforming growth factor alpha and N-myc which have been described previously in glioblastoma were not observed in T3095. There was, however, an 8-fold met amplification. Giemsa-stained metaphases of T3095 cells revealed multiple (> 5) double minutes (dmins) in the majority of cells. Following xenografting in nude mice there was a significant increase in the number and frequency of dmins. The increase in dmins correlates with the level of met amplification (50-fold), suggesting localisation of the amplified met on dmins. Here we report the first case of met amplification in glioblastoma. Correlation between met amplification and extrachromosomal elements (dmins) has not been reported previously.

Entities:  

Mesh:

Year:  1993        PMID: 8280494     DOI: 10.1016/0959-8049(93)90460-w

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Deregulated expression of c-Myc in a translocation-negative plasmacytoma on extrachromosomal elements that carry IgH and myc genes.

Authors:  F Wiener; T I Kuschak; S Ohno; S Mai
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation.

Authors:  Patrick T Grogan; Jann N Sarkaria; Barbara N Timmermann; Mark S Cohen
Journal:  Invest New Drugs       Date:  2014-04-10       Impact factor: 3.850

Review 3.  Molecular neuropathology of astrocytic brain tumors.

Authors:  T Pietsch; O D Wiestler
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

4.  Cytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt/mTOR and MAPK signaling pathways.

Authors:  Patrick T Grogan; Kristina D Sleder; Abbas K Samadi; Huaping Zhang; Barbara N Timmermann; Mark S Cohen
Journal:  Invest New Drugs       Date:  2012-11-06       Impact factor: 3.850

5.  Mosaicism for Receptor Tyrosine Kinase Activation in a Glioblastoma Involving Both PDGFRA Amplification and NTRK2 Fusion.

Authors:  Daniel J Shepherd; Tyler E Miller; Deborah A Forst; Pamela Jones; Valentina Nardi; Maria Martinez-Lage; Anat Stemmer-Rachamimov; Ramon G Gonzalez; A John Iafrate; Lauren L Ritterhouse
Journal:  Oncologist       Date:  2021-06-08

6.  Molecular cytogenetic analysis of 11 new breast cancer cell lines.

Authors:  F Forozan; R Veldman; C A Ammerman; N Z Parsa; A Kallioniemi; O P Kallioniemi; S P Ethier
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

7.  A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme.

Authors:  Hayley Nehoff; Neha N Parayath; Melanie J McConnell; Sebastien Taurin; Khaled Greish
Journal:  Oncotarget       Date:  2015-11-10

8.  Modulation of motility and proliferation of glioma cells by hepatocyte growth factor.

Authors:  S Yamamoto; H Wakimoto; M Aoyagi; K Hirakawa; H Hamada
Journal:  Jpn J Cancer Res       Date:  1997-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.